Horizon Finance (HRZN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 Aug, 2026Executive summary
Completed merger with Monroe Capital Corporation in April, expanding the equity base and portfolio, with former MRCC stockholders now owning 29.86% of the combined company and incurring $4.4 million in non-recurring merger expenses.
Focused on strengthening underwriting, credit capabilities, technology, and origination platform, with emphasis on secured debt investments in technology, life science, healthcare, and sustainability sectors.
Debt investment portfolio grew for the third consecutive quarter, reaching $677 million, with a total portfolio of $676.7 million at quarter end.
Actively building a robust pipeline of venture debt and small cap public company investments, with committed backlog increasing to $228 million.
Net asset value per share ended at $6.23, down from $6.98 at December 31, 2025, due to unrealized losses on a single portfolio company.
Financial highlights
Total investment income for Q2 2026 was $25.0 million, up from $24.5 million year-over-year.
Net investment income for Q2 2026 was $7.4 million ($0.11 per share), down from $11.4 million ($0.28 per share) year-over-year, mainly due to merger costs.
Debt investment portfolio at June 30, 2026: $648 million in debt, $17 million in warrants, $4 million in other investments, $8 million in equity, and $0.2 million in RoHo JV.
Portfolio yield on debt investments was 14.9% for Q2 2026, among the highest in the BDC industry.
Total expenses for Q2 were $17.4 million, up from $12.7 million in Q2 2025, mainly due to $4.4 million in one-time merger expenses.
Outlook and guidance
Board declared regular and special monthly cash distributions totaling $0.27 per share for Q4 2026; undistributed spillover income as of June 30, 2026 was $0.33 per share.
Management expects to leverage a stronger balance sheet and robust pipeline to grow the portfolio and deliver NII at or above declared distributions over time.
Anticipate continued portfolio growth in Q3, supported by a strong pipeline and $228 million committed backlog.
Management expects current cash, operations, and credit facilities to be sufficient for at least the next 12 months.
Latest events from Horizon Finance
- Annual meeting to elect directors and ratify new auditor, with strong governance focus.HRZN
Proxy filing - Merger added $141.1M, portfolio grew, and $0.27/share Q3 2026 distributions declared.HRZN
Q1 2026 - Supplemental distributions proposed to enhance shareholder value amid merger approval process.HRZN
Proxy Filing - Q4 portfolio growth, 14.3% yield, $647M assets, and merger set for future expansion.HRZN
Q4 2025 - Net investment income rose to $14M, with an 18.6% yield and $0.33/share distributions declared.HRZN
Q3 2025 - Merger creates a $446M NAV BDC, delivering a 33% NAV premium and scale benefits.HRZN
Q2 2025 - Net investment income fell, but portfolio growth and strong liquidity supported distributions.HRZN
Q3 2024 - Portfolio yield held at 15.9% as NII and NAV fell, with growth expected in H2 2024.HRZN
Q2 2024 - NII covered distributions in 2024, but NAV fell; strong yield and liquidity support 2025 growth.HRZN
Q4 2024